About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,029 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,029 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 601-620 of 8,029 trials

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIsThe goal of this prospective study is to explore the safety and preliminary efficacy of stereotactic body radiotherapy (SBRT) combined with ORIENT-31 regimen (Sintilimab plus…NCT06775743·Shanghai, Shanghai Municipality

UnknownStudy to Evaluate the Safety of Nanoxel M Inj.Study to evaluate the safety of Nanoxel M inj. administration in patients.NCT04066335·Seoul

UnknownZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00021008

Not yet recruitingAcupuncture and Laser Acupuncture for Advanced Non-Small Cell Lung CancerThis three-arm randomized controlled clinical trial evaluates the clinical efficacy and safety of needle acupuncture and laser acupuncture compared with placebo (sham) laser…NCT07879768·Taichung

Not yet recruitingBiomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyThis research trial studies biomarkers in predicting treatment response in samples from patients with early-stage non-small cell lung cancer previously treated with adjuvant…NCT01595074·Kingston, Ontario

RecruitingPhase 2 Study of Fingolimod in Lung CancersThis is a single-institution, open-labeled study using fingolimod (FTY720/Gilenya) in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) who have…NCT06424067·Charleston, South Carolina

TerminatedErlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung CancerThis phase II trial studies how well erlotinib hydrochloride works before surgery in treating patients with stage III non-small cell lung cancer.NCT01857271·New York, New York and 2 others

Active not recruitingTHIO Sequenced With Cemiplimab in Advanced NSCLCTHIO is a first-in-class small molecule telomere targeting agent, in development for the treatment of non-small cell lung cancer (NSCLC) in combination with cemiplimab (LIBTAYO®).NCT05208944·Birmingham, Alabama and 39 others

RecruitingA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II…NCT07169734·Phoenix, Arizona and 40 others

Not yet recruitingA Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLCA phase 3 study to evaluate the efficacy and safety of SY-3505 vs. crizotinib in patients with ALK-positive non-small cell lung cancer who had not received prior systemic therapy.NCT06254599·Beijing

RecruitingReal-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain MetastasesThis is a multicenter, non-interventional, observational real-world study to evaluate the efficacy and safety of Taletrectinib in ROS1-positive non-small cell lung cancer (NSCLC)…NCT07008287·Hangzhou, Zhejiang

CompletedEffects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer PatientsWeight loss commonly occurs in lung cancer patients, negatively influencing their quality of life, treatment response and survival.NCT01172314·Little Rock, Arkansas

CompletedStudy to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLCA prospective, multicenter, Phase-IV clinical trial to assess safety of Durvalumab in Indian adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC)NCT04416633·Bangalore and 11 others

Not yet recruitingIntegrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLCThis is a prospective, open, multicenter, Phase II single-arm clinical study.NCT06908733

TerminatedC-TIL051 in Non-Small Cell Lung CancerThe goal of this Phase 1 clinical study is test tumor infiltrating lymphocytes (known as C-TIL051) with NKTR-255 and anti-PD1 therapy for subjects with refractory non-small cell…NCT05676749·New Orleans, Louisiana and 2 others

RecruitingD-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLCThis study is a single-arm prospective single-center phase II study. Subjects are untreated resectable II-IIIIA or potentially resectable T3-4N2 stage IIIB NSCLC.NCT07016126·Guangzhou, Guangdong

RecruitingA Study of Sotorasib in People With Non-Small Cell Lung CancerThe researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation…NCT06582771·Basking Ridge, New Jersey and 6 others

CompletedRELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in CanadaIn the RELEVANCE study, we will develop a scalable electronic medical report data capture platform to collect and analyse real-world data in the stage III NSCLC population in…NCT05933044·Calgary, Alberta and 4 others

CompletedEpidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINTo provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of…NCT00831909·Antwerp and 161 others

PreviousPage 31 of 402Next